Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
This study is currently recruiting patients.
Sponsored by: | M.D. Anderson Cancer Center |
---|---|
Information provided by: | National Cancer Institute (NCI) |
Purpose
RATIONALE: Acupressure may help to reduce or prevent nausea in patients who are undergoing chemotherapy. It is not yet known whether acupressure plus standard care for nausea is more effective than standard care alone for nausea in women who are receiving chemotherapy for breast cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of acupressure in treating nausea in women who are receiving combination chemotherapy for breast cancer.
Condition | Treatment or Intervention | Phase |
---|---|---|
Breast Cancer nausea and vomiting |
Procedure: acupressure therapy Procedure: cancer prevention intervention Procedure: complementary and alternative therapy Procedure: complications of therapy assessment/management Procedure: manipulative and body-based interventions Procedure: nausea and vomiting therapy Procedure: supportive care/therapy |
Phase III |
MedlinePlus related topics: Breast Cancer; Nausea and Vomiting
Genetics Home Reference related topics: breast cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Acupressure for Chemotherapy-Induced Nausea in Women With Breast Cancer Receiving One of Three Combination Therapy Regimens
OBJECTIVES:
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to chemotherapy regimen (doxorubicin and cyclophosphamide vs doxorubicin, cyclophosphamide, and fluorouracil vs doxorubicin with paclitaxel or docetaxel vs fluorouracil, epirubicin, and cyclophosphamide) and treatment setting. Patients are randomized to 1 of 3 arms.
PROJECTED ACCRUAL: A total of 244 patients will be accrued for this study within 2 years.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS: Age
Sex
Menopausal status
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
PRIOR CONCURRENT THERAPY: Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
Location and Contact Information
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |